These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 35935787)

  • 41. New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease.
    Hartmann P; Schnabl B
    Semin Liver Dis; 2021 Jan; 41(1):87-102. PubMed ID: 33957682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut Barrier and Microbiota in Cirrhosis.
    Philips CA; Augustine P
    J Clin Exp Hepatol; 2022; 12(2):625-638. PubMed ID: 35535069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
    Aitbaev KA; Murkamilov IT; Fomin VV
    Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases.
    Liu C; Wang YL; Yang YY; Zhang NP; Niu C; Shen XZ; Wu J
    FASEB J; 2021 Oct; 35(10):e21871. PubMed ID: 34473374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microbiota, a key player in alcoholic liver disease.
    Cassard AM; Ciocan D
    Clin Mol Hepatol; 2018 Jun; 24(2):100-107. PubMed ID: 29268595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New perspective on fecal microbiota transplantation in liver diseases.
    Suk KT; Koh H
    J Gastroenterol Hepatol; 2022 Jan; 37(1):24-33. PubMed ID: 34734433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review.
    Baldi S; Mundula T; Nannini G; Amedei A
    World J Gastroenterol; 2021 Oct; 27(39):6715-6732. PubMed ID: 34754163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut-liver axis.
    Delzenne NM; Knudsen C; Beaumont M; Rodriguez J; Neyrinck AM; Bindels LB
    Proc Nutr Soc; 2019 Aug; 78(3):319-328. PubMed ID: 30628563
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intake of Bifidobacterium lactis Probio-M8 fermented milk protects against alcoholic liver disease.
    He Q; Yang C; Kang X; Chen Y; Zhang T; Zhang H; Kwok LY
    J Dairy Sci; 2022 Apr; 105(4):2908-2921. PubMed ID: 35086715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Probiotics, prebiotics, synbiotics, and fecal microbiota transplantation in the treatment of behavioral symptoms of autism spectrum disorder: A systematic review.
    Tan Q; Orsso CE; Deehan EC; Kung JY; Tun HM; Wine E; Madsen KL; Zwaigenbaum L; Haqq AM
    Autism Res; 2021 Sep; 14(9):1820-1836. PubMed ID: 34173726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective.
    Zafari N; Velayati M; Fahim M; Maftouh M; Pourali G; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
    Life Sci; 2022 Sep; 305():120760. PubMed ID: 35787997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut dysbiosis correction contributes to the hepatoprotective effects of
    Yan X; Wang Y; Ren XY; Liu XY; Ma JM; Song RL; Wang XH; Dong Y; Yu AX; Fan QQ; Wei J; She GM
    Food Funct; 2021 Oct; 12(20):10281-10290. PubMed ID: 34549762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gut Microbiota and Chronic Constipation: A Review and Update.
    Ohkusa T; Koido S; Nishikawa Y; Sato N
    Front Med (Lausanne); 2019; 6():19. PubMed ID: 30809523
    [No Abstract]   [Full Text] [Related]  

  • 55. Gut Microbiota Interventions for the Management of Obesity: A Literature Review.
    Gill VJS; Soni S; Shringarpure M; Anusheel ; Bhardwaj S; Yadav NK; Patel A; Patel A
    Cureus; 2022 Sep; 14(9):e29317. PubMed ID: 36161997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.
    Way GW; Jackson KG; Muscu SR; Zhou H
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
    Amabebe E; Robert FO; Agbalalah T; Orubu ESF
    Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.
    Paolella G; Mandato C; Pierri L; Poeta M; Di Stasi M; Vajro P
    World J Gastroenterol; 2014 Nov; 20(42):15518-31. PubMed ID: 25400436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
    da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
    Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.